DEVELOPING OF A NATURAL PRODUCT TO PREVENT AND ACHIEVE THE SIDE EFFECTS OF CHIMOTHERAPEUTIC TREATMENT

The aim of the proposal of "Businesslab" 00D is to solve a global problem for the society through the implementation of research and development activities. The team has great scientific experience and is involved in creating and implementing innovative products in the market, received a number of awards such as Pythagoras 2016 and 2018. The main objective of the project is to develop an entrepreneurial idea and an innovative product to prevent the side effects of chemotherapy (ProtChemoTerapy). Conventional treatment of various malignancies involves mainly surgical, radiological and chemotherapeutic treatment. Applying treatments often cause various adverse side effects for patients, and even more alarming is that in many cases they are ineffective, as cells exhibit resistance to therapeutics. Therefore, the search for new natural products is the goal of many labs in the world and the entrepreneurial idea of ​​"Businesslab" OOD for the development of an innovative product. This will be achieved after the establishment of a highly qualified team and inclusion of a person with permanent disabilities; purchase of equipment; consumables and materials and external services to develop the innovative active ingredients from snails. For this purpose, chromatographic, mass spectrometric, microscopic and other methods will be applied. Another important task of the project proposal is the development of environmentally friendly extraction technologies and their combined application in the preparation of ProtChemoTerapy, with a wide range of activities and in compliance with Objective 1 of the Biotechnology priority axis, with a direct application for a healthy way of life. " As a result of the implementation of the project, it is anticipated by the development of innovative technology that ProtChemoTerapy is a product that has a lasting synergistic effect - antimicrobial, restoring and protecting against the side effects of chemotherapy, which are a pandemic of our time.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 09 Aug, 2019
End date 09 Feb, 2021
Contract date 09 Aug, 2019
View in UMIS

Financial information

Total cost 200,000.00
Grant 160,000.00
Self finance 40,000.00
Total paid 79,131.32
EU participation percent 85.0%

Location